ContextVision AB (publ) (CONTX.OL)

NOK 5.7

(4.78%)

Market Cap (In NOK)

440.99 Million

Revenue (In NOK)

132.6 Million

Net Income (In NOK)

32.72 Million

Avg. Volume

83.53 Thousand

Currency
NOK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.52-9.2
PE
-
EPS
-
Beta Value
1.099
ISIN
SE0014731154
CUSIP
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Dr. Gerald Potzsch
Employee Count
-
Website
https://www.contextvision.com
Ipo Date
2000-01-03
Details
ContextVision AB (publ), a medical technology software company, provides image analysis and artificial intelligence software solutions to original equipment manufacturers in Asia, Europe, and the United States. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Its products include Rivent that offers unparalleled image quality for various types of ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; VolarView, an image enhancement software for the handheld ultrasound market segment; and GOPiCE, a technology for volumetric image enhancement in real-time. The company also provides Altumira/Altumira Plus, a platform for digital radiography; and Orthopedic Package for orthopedic imaging. In addition, it offers GOPView MRI2Plus, an image enhancement solution for MRI; and INIFY Prostate Screening for digital analysis of prostate biopsies. The company was founded in 1983 and is headquartered in Stockholm, Sweden.